APA

Banse C., Polena H., Stidder B., Khalil-Mgharbel A., Houivet E., Lequerré T., Fardellone P., Le-Loët X., Philippe P., Marcelli C., Vittecoq O. & Vilgrain I. (20180716). Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab. : Joint bone spine.

Chicago

Banse Christopher, Polena Helena, Stidder Barry, Khalil-Mgharbel Abir, Houivet Estelle, Lequerré Thierry, Fardellone Patrice, Le-Loët Xavier, Philippe Peggy, Marcelli Christian, Vittecoq Olivier and Vilgrain Isabelle. 20180716. Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab. : Joint bone spine.

Harvard

Banse C., Polena H., Stidder B., Khalil-Mgharbel A., Houivet E., Lequerré T., Fardellone P., Le-Loët X., Philippe P., Marcelli C., Vittecoq O. and Vilgrain I. (20180716). Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab. : Joint bone spine.

MLA

Banse Christopher, Polena Helena, Stidder Barry, Khalil-Mgharbel Abir, Houivet Estelle, Lequerré Thierry, Fardellone Patrice, Le-Loët Xavier, Philippe Peggy, Marcelli Christian, Vittecoq Olivier and Vilgrain Isabelle. Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab. : Joint bone spine. 20180716.